141 related articles for article (PubMed ID: 38681110)
21. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria.
Kennedy NT; Ikechukwu D; Goddy B
Pan Afr Med J; 2016; 23():85. PubMed ID: 27222684
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria.
Durowade KA; Osagbemi GK; Salaudeen AG; Musa OI; Akande TM; Babatunde OA; Raji HO; Okesina BS; Fowowe AA; Ibrahim OO; Kolawole OM
J Prev Med Hyg; 2012 Dec; 53(4):213-9. PubMed ID: 23469591
[TBL] [Abstract][Full Text] [Related]
24. The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India.
Anderson JR; Yogeshkumar S; Lu E; Yenokyan G; Thaler K; Mensa M; Chikaraddi S; Lokare L; Gudadinni MR; Antartani R; Donimath K; Patil B; Bidri S; Goudar SS; Derman R; Dalal A;
BJOG; 2023 Nov; 130 Suppl 3(Suppl 3):158-167. PubMed ID: 37932903
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer screening outcomes in public health facilities in three states in Nigeria.
Lawson O; Ameyan L; Tukur Z; Dunu S; Kerry M; Okuyemi OO; Yusuf Z; Fasawe O; Wiwa O; Hebert KS; Joseph JT; Nwokwu UE; Okpako O; Chime CI
BMC Public Health; 2023 Sep; 23(1):1688. PubMed ID: 37658293
[TBL] [Abstract][Full Text] [Related]
26. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
Fentie AM; Tadesse TB; Gebretekle GB
BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer in the Hauts-Bassins region of Burkina Faso: Results of a screening campaign by visual inspection with acetic acid (VIA screening in Burkina Faso).
Kagoné TS; Paré PG; Dembélé A; Kania D; Zida S; Bonané/Thiéba B; Ouédraogo A; Testa J; Simporé J; Méda N
Afr J Reprod Health; 2022 Jun; 26(6):97-103. PubMed ID: 37585062
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
Daniel GO; Musa J; Akindigh TM; Shinku F; Shuaibu SI; Kwaghe B; Afolaranmi T; Okpala C; Agbaji O; Sagay A
Int J Gynaecol Obstet; 2020 Nov; 151(2):253-259. PubMed ID: 32683675
[TBL] [Abstract][Full Text] [Related]
30. Risk factors of precancerous cervical lesions: The role of women's socio-demographic, sexual behavior and body mass index in Amhara region referral hospitals; case-control study.
Taye BT; Mihret MS; Muche HA
PLoS One; 2021; 16(3):e0249218. PubMed ID: 33770125
[TBL] [Abstract][Full Text] [Related]
31. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
32. Sociodemographic and gynaecological factors that influence uptake of cervical cancer screening. A cross-sectional study in Calabar, Nigeria.
Ago BU; Efiok EE; Abeng SE
Afr Health Sci; 2022 Dec; 22(4):96-103. PubMed ID: 37092061
[TBL] [Abstract][Full Text] [Related]
33. Motivations and preferences of rural Nigerian women undergoing cervical cancer screening via visual inspection with acetic acid.
Chigbu CO; Onyebuchi AK; Ajah LO; Onwudiwe EN
Int J Gynaecol Obstet; 2013 Mar; 120(3):262-5. PubMed ID: 23228820
[TBL] [Abstract][Full Text] [Related]
34. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer prevention in Senegal: an International Cooperation Project Report.
Gabrielli S; Maggioni E; Fieschi L
Acta Biomed; 2018 Jul; 89(6-S):29-34. PubMed ID: 30038201
[TBL] [Abstract][Full Text] [Related]
36. Fighting cervical cancer in Africa: a cross-sectional study on prevalence and risk factors for precancerous lesions in rural Uganda.
Christensen AJ; Mwayi J; Mbabazi J; Juncker M; Kallestrup P; Kraef C
Public Health; 2023 Dec; 225():87-95. PubMed ID: 37922591
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study.
Beyene T; Akibu M; Bekele H; Seyoum W
PLoS One; 2021; 16(7):e0254663. PubMed ID: 34265004
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.
Tekpor E; Effah K; Sifa J; Amuah JE; Essel NOM; Kemawor S; Wormenor CM; Sesenu E; Danyo S; Akakpo PK
BMC Public Health; 2024 Mar; 24(1):659. PubMed ID: 38429784
[TBL] [Abstract][Full Text] [Related]
39. Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia.
Derbie A; Amare B; Misgan E; Nibret E; Maier M; Woldeamanuel Y; Abebe T
PLoS One; 2022; 17(9):e0274466. PubMed ID: 36094938
[TBL] [Abstract][Full Text] [Related]
40. Providing TB and HIV outreach services to internally displaced populations in Northeast Nigeria: Results of a controlled intervention study.
Abdullahi SA; Smelyanskaya M; John S; Adamu HI; Ubochioma E; Kennedy I; Abubakar FA; Ago HA; Stevens R; Creswell J
PLoS Med; 2020 Sep; 17(9):e1003218. PubMed ID: 32903257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]